menu
    • menu

    Company profile for INmune Bio

    NEW Drugs in Dev: 5
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    INmune Bio Inc. is a clinical stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. INKmune, the company’s lead product, primes patient’s NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a ...
    INmune Bio Inc. is a clinical stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. INKmune, the company’s lead product, primes patient’s NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells’ ability to eliminate residual disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    INmune BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1200 Prospect Street Suite 525 La Jolla, California 92037
    Telephone
    Telephone
    858 964 3720
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.inmunebio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/inmune-bio-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/INmuneBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Inmune Bio Reveals 2025 Results And Business Update
    Inmune Bio Reveals 2025 Results And Business Update

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264946/0/en/INmune-Bio-Inc-Announces-2025-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Inmune Bio To Report 2025 Financials And Corporate Update
    Inmune Bio To Report 2025 Financials And Corporate Update

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261162/0/en/INmune-Bio-Inc-to-Report-Year-End-2025-Financial-Results-and-Provide-Corporate-Update-on-Monday-March-30th.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    Inmune Bio Showcases Mindful Trial At AD/PD 2026 Plenary
    Inmune Bio Showcases Mindful Trial At AD/PD 2026 Plenary

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3258912/0/en/INmune-Bio-s-MINDFuL-Trial-Featured-at-AD-PD-2026-Plenary-as-Successful-Example-of-How-to-Approach-Clinical-Trials-Targeting-Inflammation-in-Early-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Inmune Bio Unveils Xpro1595 Plan In Alzheimer's Webinar
    Inmune Bio Unveils Xpro1595 Plan In Alzheimer's Webinar

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242715/0/en/INmune-Bio-to-Detail-XPro1595-Registrational-Strategy-in-Upcoming-Alzheimer-s-Webinar.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    INmune to Host Webinar on CORDStrom Data
    INmune to Host Webinar on CORDStrom Data

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3241400/0/en/INmune-Bio-Announces-Upcoming-Webinar-to-Present-New-Clinical-Data-on-CORDStrom-for-RDEB.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    INmune Bio Secures FDA Alignment for XPro1595 in Early AD
    INmune Bio Secures FDA Alignment for XPro1595 in Early AD

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237062/0/en/INmune-Bio-Announces-FDA-Alignment-on-Integrated-Phase-2b-3-Registration-Pathway-for-XPro1595-in-Early-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search